多发性硬化症:是时候用高效药物早期治疗
Krzysztof Selmaj1,2, Bruce A C Cree3, Michael Barnett4
1Department of Neurology, University of Warmia and Mazury, 30 Warszawska Ave, 10-082, Olsztyn, Poland. kselmaj@gmail.com.
Journal of neurology
|October 18, 2023
概括
在多发性硬化症 (MS) 患者中,早期使用高效治疗药物 (HETA) 治疗导致更好的结果. 这种方法减少了复发率和残疾进展,提供了显著的长期好处.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 传统的多发性硬化症 (MS) 治疗涉及从低效药物 (LETA) 升级治疗.
- 最近的数据挑战了这种方法,表明早期使用高效治疗剂 (HETA) 可能更有益.
研究的目的:
- 审查目前MS治疗策略的变化.
- 评估早期HETA与LETA的疗效和安全性.
主要方法:
- 对随机,双盲,III期研究进行分析,比较HETA和LETA.
- 使用先进的统计方法 (倾向评分,边缘结构建模) 检查基于人口的研究.
主要成果:
- 早期启动HETA显著降低了年复发率 (ARR) 和10到15年的残疾进展.
- 与较旧的高效药物相比,较新的HETA药物表现出更好的安全性.
- 患者的偏好正在转向提供症状改善和疾病预防的治疗方法.
结论:
- 来自临床试验和人口研究的证据支持在MS管理中更广泛地采用早期HETA.
- 用HETA进行主动治疗利用了影响MS病理学的关键窗口.
- 这标志着向主动性MS管理的转变,远离治疗失败驱动的策略.
相关概念视频
Alzheimer's Disease: Treatment
200
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
200
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
Psychosis: Goals of Pharmacotherapy
145
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
145
Parkinson's Disease: Treatment
281
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
281
Antiepileptic Drugs: Glutamate Antagonists
383
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
383
Drug Therapy
47
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
47


